The first innovation studio dedicated exclusively to blue biotechnology is now up and running in the state of Maine, United States, bringing together 10 international teams with a common goal: transforming marine resources into high-value commercial products.

According to a report published by Fish Site, the programme, named Maine Blue Biotech Studio 2026, was designed to accelerate the transition from scientific research to industrial-scale solutions, in a sector where the gap between innovation and market uptake remains one of the main barriers to investment.

The initiative is led by Hatch Blue, in partnership with Bigelow Laboratory for Ocean Sciences and supported by Maine Technology Institute. Over the coming weeks, founders will work immersed in the local ecosystem, with access to specialised mentorship, scientific infrastructure, and direct engagement with industry and investors.

Scaling marine innovation and resource valorisation

The selected cohort includes companies from the United States, Norway, Canada and Germany, working across areas such as algae innovation, aquaculture health, biomaterials and marine circularity. Solutions under development include biomaterials derived from fish byproducts, seaweed-based edible coatings to extend the shelf life of fresh products, oral vaccines for aquaculture using microalgae, and processes to convert shellfish waste into high-value compounds such as chitosan.

According to the programme organisers, the goal is to create the conditions for these technologies to evolve into viable and investable business models, through an intensive support framework combining one-to-one mentorship, real-world validation and integration into existing value chains.

“This is the first programme of its kind focused specifically on blue biotechnology,” said Dylan Terry, studio director at Hatch Blue, as quoted by Fish Site. “The aim is to give founders the time, connections and support needed to turn promising marine technologies into scalable businesses.”

Bridging the “valley of death”

Maine has been positioning itself as a strategic hub in this field, combining abundant marine resources, leading research institutions and a strong coastal business community. The region hosts one of the fastest-growing seaweed aquaculture industries in the United States and benefits from proximity to Boston’s life sciences ecosystem, strengthening its ability to attract talent, investment and partnerships.

Beth Orcutt, vice president for research at Bigelow Laboratory for Ocean Sciences, also quoted by Fish Site, highlighted that the state is emerging as a “testbed” for blue biotechnology innovation, offering unique conditions to develop and scale new solutions.

The launch of this studio comes at a time when the blue bioeconomy is entering a new phase, marked by the need to translate scientific knowledge into tangible applications capable of generating economic value and attracting investment. Beyond developing new technologies, the challenge now lies in ensuring they can overcome the so-called “valley of death” between research and market deployment.